Twitter

Archive for August 13th, 2012


Signs, symptoms and treatments for prostate cancer – Dr. Sam Chawla

Dr. Sam Chawla with Wake Specialty Physicians — Urology discusses signs, symptoms and treatments for prostate cancer.

Read More...

Steroid-Induced Osteoporosis in the Pediatric Population – Canadian Incidence Study

Conditions :   Acute Lymphoblastic Leukemia;   Nephrotic Syndrome;   Rheumatism Intervention :   Sponsors :   Children’s Hospital of Eastern Ontario;   Children’s Hospital of Eastern Ontario;   Canadian Institutes of Health Research (CIHR) Active, not recruiting – verified August 2012

Read More...

Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin’s Lymphoma.

Condition :   Lymphoma, Non-Hodgkin Intervention :   Biological: cycolophosphamide, vacristine, and pednisone (CVP) x6 cycles followed by tositumomab and iodine I 131 tositumomab. Sponsors :   GlaxoSmithKline;   GlaxoSmithKline Completed – verified August 2012

Read More...

Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma

Conditions :   Anaplastic Astrocytomas;   Anaplastic Oligodendrogliomas;   Glioblastomas (GBM) Intervention :   Drug: NKTR-102 Sponsors :   Stanford University;   Lawrence Recht;   Nektar Therapeutics Recruiting – verified August 2012

Read More...

Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV

Conditions :   Anal Dysplasia;   Human Papilloma Virus;   HIV Interventions :   Drug: imiquimod;   Procedure: ablative Sponsors :   United States Naval Medical Center, San Diego;   United States Naval Medical Center, San Diego Not yet recruiting – verified August 2012

Read More...

Phase I Study of Milatuzumab for Graft Versus Host Disease

Conditions :   GVHD (Acute or Chronic);   Acute Myeloid or Lymphoblastic Leukemia (AML or ALL);   Myelodysplastic Syndrome;   Chronic Myelogenous Leukemia (CML);   Multiple Myeloma (MM);   Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell);   Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL) Intervention :   Drug: milatuzumab Sponsors :   Immunomedics, Inc.;   Immunomedics, Inc.;   Ohio State University Not yet recruiting – verified August 2012

Read More...

Diagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and Brachytherapy

Condition :   Squamous-cell Cervical Carcinoma Stage IB2 to IIB Without Spread to Lymph Nodes or Metastasis Intervention :   Device: 18F-FDG-PET Sponsors :   Hospices Civils de Lyon;   Hospices Civils de Lyon Recruiting – verified August 2012

Read More...

Technology and Navigation to Improve Survivorship Care

Condition :   Breast Cancer Interventions :   Behavioral: Audio Recorded Interviews;   Behavioral: Focus Group Session;   Other: Website Session;   Behavioral: Questionnaire Sponsors :   M.D. Anderson Cancer Center;   M.D. Anderson Cancer Center Not yet recruiting – verified August 2012

Read More...

A Study of LY2228820 for Recurrent Ovarian Cancer

Condition :   Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Interventions :   Drug: LY2228820;   Drug: Carboplatin;   Drug: Placebo;   Drug: Gemcitabine Sponsors :   Eli Lilly and Company;   Eli Lilly and Company Not yet recruiting – verified August 2012

Read More...

STAT3 in T Cells: At The Crossroads of Inflammation and Cancer

Condition :   Cutaneous T Cell Lymphoma Intervention :   Sponsors :   New York University School of Medicine;   New York University School of Medicine Recruiting – verified August 2012

Read More...